Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | — | 3.9B | 2.6B | 2.5B |
| Cost of revenue | 1.6B | 1.7B | 1.5B | 1.5B |
| Gross profit | — | 2.2B | 1.1B | 1.0B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | -14M | 61M | 86M |
| Other operating expenses | — | — | — | — |
| Operating income | — | 2.0B | 1.0B | 953M |
| Non operating interest income | ||||
| Income | — | — | 281M | 241M |
| Expense | — | 42M | 350M | 388M |
| Other income expense | — | — | — | — |
| Pretax income | — | 1.1B | 672M | 684M |
| Tax provision | — | 476M | 31M | 123M |
| Net income | — | 635M | 640M | 608M |
| Basic EPS | — | — | 21.8 | 20.5 |
| Diluted EPS | — | — | 21.8 | 20.5 |
| Basic average shares | — | — | 18.5M | 18.6M |
| Diluted average shares | — | — | 18.5M | 18.6M |
| EBITDA | — | 2.8B | 1.9B | 1.7B |
| Net income from continuing op. | — | 635M | 640M | 608M |
| Minority interests | — | -285M | -237M | -226M |
| Preferred stock dividends | — | 0 | 0 | 0 |